USPTO serial 87102856
SHIRE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2020
- Examiner
- KENEALY, NATALIE LANGFORD
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SHIRE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shire Pharmaceutical Holdings Ireland Limited
Dublin 2, IE
Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
Shire Pharmaceutical Holdings Ireland Limited
Dublin 2, IE
Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
SHIRE PHARMACEUTICALS IRELAND LIMITED
DUBLIN, IE
Other trademarks owned by SHIRE PHARMACEUTICALS IRELAND LIMITED
TAKEDA PHARMACEUTICALS INTERNATIONAL AG
GLATTPARK-OPFIKON, CH
Other trademarks owned by TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Shire Pharmaceutical Holdings Ireland Limited
Dublin 24, IE
Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki
Karl M. Zielaznicki Troutman Pepper Hamilton Sanders LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A full line of pharmaceuticals, namely, pharmaceuticals for the treatment of angioedema, cancer, eating disorders, enzyme deficiencies, gastrointestinal disorders, genetic diseases, hematologic disorders, hormonal disorders, immunologic disorders, neurological disorders, ophthalmic disorders and protein deficiencies; drug delivery apparatus, namely, pre-filled medical fluid injectors for the delivery of pharmaceuticals | ACTIVE | — |
| 044 | Providing medical information and health care information; Providing medical information and health care information in connection with patient support programs; Providing medical information and health care information to improve understanding about pharmaceuticals and medical treatments by health care providers, patients, patients' families and the general public; Health care services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
- Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
- Other trademarks owned by SHIRE PHARMACEUTICALS IRELAND LIMITED
- Other trademarks owned by TAKEDA PHARMACEUTICALS INTERNATIONAL AG
- Other trademarks owned by Shire Pharmaceutical Holdings Ireland Limited
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named SHIRE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 17, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 23, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 25, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 14, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 13, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2020 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 14, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 14, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 26, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 25, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jun 25, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 18, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 17, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 17, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 15, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 15, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 6, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 6, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 4, 2019 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 4, 2019 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 4, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 8, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 4, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 4, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 7, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 5, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 5, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 5, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 9, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 7, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 7, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 7, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 18, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 10, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2016 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 28, 2016 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 28, 2016 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 24, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 16, 2016 | NWAP | NEW APPLICATION ENTERED | — |